Status:
COMPLETED
Project SMART Automated Pillbox Study
Lead Sponsor:
Yale University
Collaborating Sponsors:
National Institutes of Health (NIH)
University at Albany
Conditions:
HIV/AIDS
Cocaine Use
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to examine the effect of mHealth tools on antiretroviral (ART) adherence and persistence among HIV-infected individuals with co-occurring cocaine use disorders (CUDs).
Detailed Description
To conduct qualitative assessments using focus groups of people living with HIV (PLH) who use cocaine and healthcare providers that will assess the acceptability, feasibility, facilitators and barrier...
Eligibility Criteria
Inclusion
- Age equal to or greater than 18 years
- Clinic-confirmed HIV diagnosis
- Currently prescribed or eligible for ART
- Currently has insurance
- Self-reported cocaine use in the past 30 days
- Willing and able to use a cell phone and electronic pill box for the 12-week intervention
Exclusion
- Unable to provide informed consent
- Verbally or physically threatening to research staff
- Unable to communicate in either English or Spanish
Key Trial Info
Start Date :
June 8 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 18 2020
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT04418076
Start Date
June 8 2017
End Date
August 18 2020
Last Update
May 15 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yale Clinical Research
New Haven, Connecticut, United States, 06510